Dong-E-E-Jiao Co., Ltd., a subsidiary of China Resources Pharma (03320), announced its financial results for the three-month period ended March 31, 2026. The company reported total operating revenue of approximately 1.814 billion yuan, representing a year-on-year increase of 5.52%. Net profit for the quarter reached 455 million yuan, up 7.12% compared to the same period last year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments